Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 13 Dec 2024

Immunotherapy for lung adenocarcinoma patients with bone metastases: who really needs it

in Cancer Immunity and Immunotherapy

Zhangheng Huang
Yuexin Tong
Lujian Zhu
Binbin Yang
Kai Chen
Peiling Dai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1457916

867 views

Original Research

Published on 13 Dec 2024

Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Huihui Xiang
Rika Kasajima
Koichi Azuma
Tomoyuki Tagami
Asami Hagiwara
Yoshiro Nakahara
Haruhiro Saito
Yuka Igarashi
Feifei Wei
Tatsuma Ban

Frontiers in Immunology

doi 10.3389/fimmu.2024.1361992

1,453 views
1 citation

Case Report

Published on 13 Dec 2024

Case report: Two cases of pyloric adenomas with high-grade intraepithelial neoplasia at distinct locations

in Cancer Immunity and Immunotherapy

Yuetian Li
Shuai Chen
Xuechun Zhao
Quanyi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485840

495 views

Original Research

Published on 13 Dec 2024

In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models

in Cancer Immunity and Immunotherapy

Shannon Argueta
Yuxiao Wang
Hongyun Zhao
Neha Diwanji
Michael Gorgievski
Edward Cochran
Ewa Grudzien-Nogalska
Josephine D’Alessandro
Bruce McCreedy
Thomas Prod’homme

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501365

2,493 views

Case Report

Published on 13 Dec 2024

Case report: Systemic sclerosis during neoadjuvant therapy for breast cancer in a 59-year-old woman

in Cancer Immunity and Immunotherapy

Siyu Liu
Xiaomei Xiao
Fangjing Yue
Cong Su
Yujun Tong
Weiyun Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487508

945 views

Original Research

Published on 13 Dec 2024

Predicting axillary lymph node metastasis in breast cancer using a multimodal radiomics and deep learning model

in Cancer Immunity and Immunotherapy

Fuyu Guo
Shiwei Sun
Xiaoqian Deng
Yue Wang
Wei Yao
Peng Yue
Shaoduo Wu
Junrong Yan
Xiaojun Zhang
Yangang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482020

1,240 views

Original Research

Published on 13 Dec 2024

Development of a urine-based metabolomics approach for multi-cancer screening and tumor origin prediction

in Cancer Immunity and Immunotherapy

Xinping Xu
Chunyan Zeng
Bei Qing
Yun He
Guodong Song
Jiaojiao Wang
Shuqi Yu
Tao Zhang
Qingyan Wei
Li Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1449103

1,295 views

Review

Published on 13 Dec 2024

Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review

in Cancer Immunity and Immunotherapy

Lucía Serrano García
Beatriz Jávega
Antonio Llombart Cussac
María Gión
José Manuel Pérez-García
Javier Cortés
María Leonor Fernández-Murga

Frontiers in Immunology

doi 10.3389/fimmu.2024.1513421

1,979 views

Original Research

Published on 12 Dec 2024

Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features

in Cancer Immunity and Immunotherapy

Florence Boissière-Michot
Marie-Christine Chateau
Simon Thézenas
Virginie Lafont
Evelyne Crapez
Priyanka Sharma
Angélique Bobrie
Pascal Roger
Séverine Guiu
William Jacot

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507371

1,408 views

Mini Review

Published on 12 Dec 2024

Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Xianqiang Liu
Xiaowei Xi
Shengshan Xu
Hongyu Chu
Penghui Hu
Dong Li
Bin Zhang
Hejie Liu
Tianxiao Jiang
Zhuming Lu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507501

1,668 views

Review

Published on 12 Dec 2024

Targeting caspase-8: a new strategy for combating hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Haoran Chen
Yumeng Lin
Jie Chen
Xuemei Luo
Yubo Kan
Yuqi He
Renhe Zhu
Jiahui Jin
Dongxuan Li
Yi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501659

1,928 views

Original Research

Published on 12 Dec 2024

m6A methylation profiling as a prognostic marker in nasopharyngeal carcinoma: insights from MeRIP-Seq and RNA-Seq

in Cancer Immunity and Immunotherapy

Xiaochuan Chen
Wenqian Xu
Junping Pan
Hanxuan Yang
Yi Li
Xin Chen
Yingming Sun
Qinying Liu
Sufang Qiu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1492648

1,009 views

Original Research

Published on 12 Dec 2024

Cross-disease transcriptomic analysis reveals DOK3 and PAPOLA as therapeutic targets for neuroinflammatory and tumorigenic processes

in Cancer Immunity and Immunotherapy

Xingqiao Wang
Yusong Bian
Weiguang Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1504629

837 views

Review

Published on 12 Dec 2024

The potential of cellular homing behavior in tumor immunotherapy: from basic discoveries to clinical applications of immune, mesenchymal stem, and cancer cell homing

in Cancer Immunity and Immunotherapy

Dongtao Li
Yixuan Yang
Guangda Zheng
Linghan Meng
Lu Shang
Juanxia Ren
Lingyun Wang
Yanju Bao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495978

608 views

Original Research

Published on 12 Dec 2024

Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell lung cancer derived from RNA- and whole-exome sequencing: results of a prospective observational study on a cohort of 85 patients

in Cancer Immunity and Immunotherapy

Elena Poddubskaya
Maria Suntsova
Marina Lyadova
Daniil Luppov
Anastasia Guryanova
Vladimir Lyadov
Andrew Garazha
Maksim Sorokin
Anna Semenova
Vitaly Shatalov

Frontiers in Immunology

doi 10.3389/fimmu.2024.1493877

1,844 views

Case Report

Published on 12 Dec 2024

Case report: Microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response

in Cancer Immunity and Immunotherapy

Qinghua Liu
Ruoyun Li
Wei Zhu
Pengfei Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456343

848 views

Navigation group

Articles

Immunotherapy for lung adenocarcinoma patients with bone metastases: who really needs it

Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma

Case report: Two cases of pyloric adenomas with high-grade intraepithelial neoplasia at distinct locations

In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models

Case report: Systemic sclerosis during neoadjuvant therapy for breast cancer in a 59-year-old woman

Predicting axillary lymph node metastasis in breast cancer using a multimodal radiomics and deep learning model

Development of a urine-based metabolomics approach for multi-cancer screening and tumor origin prediction

Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review

Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features

Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer

Targeting caspase-8: a new strategy for combating hepatocellular carcinoma

m6A methylation profiling as a prognostic marker in nasopharyngeal carcinoma: insights from MeRIP-Seq and RNA-Seq

Cross-disease transcriptomic analysis reveals DOK3 and PAPOLA as therapeutic targets for neuroinflammatory and tumorigenic processes

The potential of cellular homing behavior in tumor immunotherapy: from basic discoveries to clinical applications of immune, mesenchymal stem, and cancer cell homing

Biomarkers of success of anti-PD-(L)1 immunotherapy for non-small cell lung cancer derived from RNA- and whole-exome sequencing: results of a prospective observational study on a cohort of 85 patients

Case report: Microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response